Nu Skin Enterprises Inc. (NYSE: NUS) announced its first quarter 2026 financial results, with revenue of $320.6 million, in line with company guidance despite a challenging market environment.
Gross margin stood at 66.9% (67.9% adjusted), with operating margin at 1.3% (3.6% adjusted). The company returned $7.9 million to shareholders through dividends and stock repurchases.
Ryan Napierski, President and CEO of Nu Skin, stated:
“We delivered first quarter revenue in line with expectations and made solid progress on our strategic priorities. We are focused on empowering our sales leaders with Prysm iO™, our latest intelligent wellness innovation, ahead of the full consumer rollout in the second half of 2026. We are also preparing for the formal launch in India later this year while strengthening operational discipline.”
Nu Skin is seeing early positive signs in new sales leader development and paid affiliates in several key markets as leaders adopt Prysm iO and leverage its biomarker tracking technology to drive customer subscriptions.
Chelsea Lantz, Interim Chief Financial Officer, added:
“In addition to meeting revenue and adjusted earnings targets, we returned $8 million to shareholders through dividends and share repurchases. We also successfully refinanced our debt to extend liquidity as we invest in growth initiatives.”
Full Year 2026 EPS: $0.70 – $1.10 (or $0.80 – $1.20 excluding certain charges)
Nu Skin Enterprises Inc. (NYSE: NUS) is an intelligent beauty and wellness company operating in nearly 50 markets worldwide. Powered by a dynamic affiliate platform and backed by over 40 years of scientific research, Nu Skin offers innovative products including the new Prysm iO™ intelligent wellness platform, award-winning beauty devices, and trusted personal care and nutrition solutions.
There are no reviews yet. Be the first one to write one.
